Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,070
Closed -$28K 998
2018
Q2
$28K Hold
6,070
﹤0.01% 609
2018
Q1
$44K Sell
6,070
-15,049
-71% -$103K 0.01% 524
2017
Q4
$136K Buy
21,119
+5,234
+33% +$33.5K 0.02% 355
2017
Q3
$105K Buy
+15,885
New +$98.4K 0.01% 388
2014
Q4
Sell
-21,120
Closed -$138K 784
2014
Q3
$138K Sell
21,120
-1,295
-6% -$9.12K 0.03% 359
2014
Q2
$158K Hold
22,415
0.03% 389
2014
Q1
$166K Buy
22,415
+5,650
+34% +$39.5K 0.03% 386
2013
Q4
$123K Buy
+16,765
New +$123K 0.03% 408

Other funds holding ABEV

Smithfield Trust's ABEV Position: Q3 2018 in Review

Smithfield Trust sold out of Ambev (ABEV) in Q3 2018, closing a stake of 6,070 shares — an estimated $28K sold.

Smithfield Trust first reported a position in ABEV in Q4 2013 and held it in 8 quarters. The position peaked at $166K in Q1 2014. 330 funds tracked by Wall St. Rank hold ABEV as of Q3 2018.

  • Smithfield Trust reported no remaining Ambev position as of Q3 2018 after selling out during the quarter.
  • Smithfield Trust sold 6,070 Ambev shares in Q3 2018, an estimated $28K.
  • Smithfield Trust first reported a position in Ambev in Q4 2013 and held it in 8 quarters.
  • Smithfield Trust's Ambev position peaked at $166K in Q1 2014.
  • 330 funds tracked by Wall St. Rank held Ambev as of Q3 2018.

Based on Smithfield Trust's 13F filing for Q3 2018, filed 5 Nov 2018.